Table 1.

Baseline characteristics of participants in the Prospective Investigation of the Vasculature in Uppsala Seniors study

Number of subjects1003
Female no. (%)497 (50)
Age (yr)70.2±0.2
Body mass index (kg/m2)27±4
Systolic BP (mmHg)150±23
Diastolic BP (mmHg)79±10
Serum total cholesterol (mg/dl)5.4±1.0
Serum HDL cholesterol (mg/dl)1.5±0.4
Fasting plasma glucose (mg/dl)5.3±1.6
Diabetes117 (12)
Smoking no. (%)109 (11)
Previous cardiovascular disease no. (%)164 (16)
Lipid-lowering treatment no. (%)159 (16)
Antihypertensive treatment no. (%)314 (31)
Estimated GFR (ml/min per 1.73 m2)80±14
Serum calcium (mg/dl)9.44±0.52
Serum phosphate (mg/dl)3.40±0.53
Serum 25(OH)D3 (nmol/L)58±20
Serum intact PTH (pmol/L)47±21
Serum FGF23 (pg/ml)47±24
Left ventricular mass (g)225±75
Left ventricular ejection fraction (%)66±8
Endothelium-dependent vasodilatation (%)529±316
Endothelium-independent vasodilatation (%)369±213
Flow-mediated dilatation (%)4.8±3.6
Pulse-wave reflection index (%)−31±14
Intima media thickness (mm)0.92±0.16
  • Data are mean ± SD for continuous variables and n (%) for categorical variables. 25(OH)D3, 25-hydroxyvitamin D3; PTH, parathyroid hormone; FGF23, fibroblast growth factor-23.